Use of Platelet-Rich Plasma (PRP) and Platelet-Poor Plasma (PPP) to Prevent Infection and Delayed Wound Healing (PRP)
|ClinicalTrials.gov Identifier: NCT01639144|
Recruitment Status : Completed
First Posted : July 12, 2012
Results First Posted : May 22, 2015
Last Update Posted : May 22, 2015
|Condition or disease||Intervention/treatment||Phase|
|Elective Foot and Ankle Surgery.||Biological: PRP and PPP||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||515 participants|
|Intervention Model:||Parallel Assignment|
|Official Title:||Use of Platelet-Rich Plasma (PRP) and Platelet-Poor Plasma (PPP) to Prevent Infection and Delayed Wound Healing After Elective Foot and Ankle Surgery in Healthy Adults|
|Study Start Date :||July 2012|
|Actual Primary Completion Date :||January 2015|
|Actual Study Completion Date :||March 2015|
Active Comparator: Receiving PRP and PPP.
Administration of PRP and PPP to surgical site.
Biological: PRP and PPP
Autogenous PRP and PPP
No Intervention: Control
Group not receiving autogenous PRP and PPP.
- Postoperative Infection and Delayed Wound Healing. [ Time Frame: Infection: 30 days after surgery. Delayed wound healing: 60 days. ]Postoperative deep incisional surgical site infection and delayed wound healing (lack of primary healing of skin edges typically with wound secretion).
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01639144
|United States, Florida|
|UHZ Sports Medicine Institute|
|Coral Gables, Florida, United States, 33146|
|Study Director:||Gary M Kiebzak, Ph.D.||Center for Research & Grants|